| Literature DB >> 15342304 |
Emmanuel M Kanoupakis1, Emmanuel G Manios, Hercules E Mavrakis, Panos G Tzerakis, Helen K Mouloudi, Panos E Vardas.
Abstract
Pretreatment with antiarrhythmic agents could improve cardioversion and recurrence rates in patients with persistent atrial fibrillation. In a prospective controlled trial, 145 patients were randomly assigned to treatment with carvedilol, amiodarone, or placebo for 4 weeks before electrical cardioversion. Although the 2 drugs had similar effects on cardioversion rates, amiodarone was superior in terms of sinus rhythm maintenance after conversion. Copyright 2004 Excerpta Medica, Inc.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15342304 DOI： 10.1016/j.amjcard.2004.05.037
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778